| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 3 | 0 | 9 | 5 | 4 | 5 | 4 | 5 | 6 | 5 | 5 | 6 | 5 | 6 | 8 | 8 | 4 | 3 | 6 | 9 | 9 | 5 | 13 | 16 | 16 | 16 | 19 | 21 | 17 | 11 | 8 | 10 | 8 | 11 | 8 | 10 | 11 | 13 | 12 | 13 | 10 | 9 | 13 |
| Expenses | 3 | 0 | 7 | 4 | 4 | 4 | 3 | 4 | 4 | 5 | 4 | 5 | 4 | 5 | 6 | 6 | 5 | 5 | 6 | 6 | 14 | 5 | 7 | 8 | 11 | 10 | 12 | 14 | 14 | 9 | 8 | 9 | 9 | 8 | 8 | 9 | 10 | 10 | 9 | 10 | 10 | 11 | 10 |
| EBITDA | 1 | 0 | 2 | 1 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 3 | -1 | -1 | 0 | 2 | -5 | 1 | 6 | 9 | 5 | 6 | 7 | 7 | 3 | 2 | -0 | 2 | -1 | 2 | 1 | 1 | 1 | 3 | 3 | 2 | -0 | -1 | 2 |
| Operating Profit % | 20 % | 0 % | 16 % | 19 % | -17 % | 16 % | 17 % | 17 % | 16 % | 9 % | 21 % | 21 % | 13 % | 22 % | 29 % | 32 % | -15 % | -42 % | -6 % | 23 % | -95 % | 15 % | 38 % | 53 % | 32 % | 36 % | 34 % | 32 % | -18 % | 12 % | -5 % | 15 % | -13 % | 20 % | 7 % | 10 % | 9 % | 25 % | 22 % | 17 % | -4 % | -20 % | 17 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | -2 | -3 | -2 | 1 | -7 | -1 | 4 | 7 | 4 | 5 | 5 | 6 | 2 | 0 | -2 | 0 | -3 | 1 | -1 | -1 | -1 | 2 | 1 | 0 | -3 | -4 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -1 | -0 | 0 | -1 | -0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | -0 | -0 | 0 | -0 | 0 | -0 | -0 | 0 | 1 | 1 | 0 | -1 | -1 | 0 |
| Net Profit | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -0 | 0 | 1 | 1 | -2 | -2 | -1 | 0 | -6 | -1 | 3 | 6 | 4 | 3 | 4 | 4 | 1 | 0 | -1 | 0 | -2 | 1 | -1 | -1 | -1 | 1 | 0 | 0 | -1 | -3 | 0 |
| EPS in ₹ | 0.70 | 0.00 | 1.50 | 0.25 | -1.77 | 0.16 | 0.20 | 0.24 | 0.51 | 0.03 | 0.09 | 0.12 | -0.05 | 0.26 | 0.93 | 0.52 | -0.97 | -1.37 | -0.95 | 0.26 | -3.56 | -0.37 | 1.79 | 3.74 | 2.56 | 2.17 | 2.45 | 2.80 | 0.52 | 0.25 | -0.78 | 0.04 | -1.51 | 0.33 | -0.39 | -0.31 | -0.47 | 0.66 | 0.16 | 0.03 | -0.81 | -2.03 | 0.01 |
Jeevan Scientific Technology
Jeevan Scientific Technology
61.00
+0.42
(0.69%)
Market Cap
96.56 Cr
PE Ratio
-21.64
Volume
4,075.00
Day High - Low
61.00 - 60.70
52W High-Low
76.99 - 32.85
Key Fundamentals
Market Cap
96.56 Cr
EPS
-0.04
PE Ratio
-21.64
PB Ratio
2.03
Book Value
29.81
EBITDA
8.10
Dividend Yield
0.00 %
Industry
Healthcare Sector
Healthcare Technology Return on Equity
0.12
Debt to Equity
0.35
Actual
Company News
View All News
Jeevan Scientific Technology Limited receives US FDA Remote Regulatory Assessment Report following review of its Hyderabad clinical pharmacology facility from October-November 2025.
Jeevan Scientific Promoters Acquire 30L Warrants
Jan 06, 2026
Jan 06, 2026Multiple promoters of Jeevan Scientific Technology acquired 30,00,000 convertible warrants through preferential allotment on January 2, with Krishna Kishore Kuchipudi leading with 12,00,000 warrants.
Jeevan Scientific Technology announces acquisition of 60% stake in Naya Pharma Private Limited for ₹10 crores, funded through preferential issue proceeds approved in November 2025.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
500.85 | #1 20,181.22 | 62.08 | #1 3,714.20 | 3.77 | #1 496 | -88.56 | 15.86 | |
462.90 | 11,124.28 | 25.57 | 2,946.50 | 10.53 | 407 | 11.34 | 20.39 | |
130.00 | 2,957.16 | -14.34 | 17.60 | -46.34 | -161 | -55.85 | 25.67 | |
515.00 | 2,298.71 | 37.26 | 322.30 | 0.22 | 41 | 112.87 | 31.64 | |
36.35 | 537.74 | #1 11.66 | 10.20 | #1 126.67 | 1 | #1 493.75 | 45.72 | |
66.00 | 155.36 | -3.51 | 806.50 | 4.78 | -56 | 22.07 | 27.69 | |
61.00 | #7 96.56 | #6 -21.64 | #6 47.50 | #2 17.87 | #6 0 | #8 -100.00 | 38.44 | |
18.75 | 26.30 | 33.09 | 84.00 | 5.00 | 2 | -76.92 | 23.67 | |
19.50 | 13.90 | -1.04 | 2.10 | -78.57 | -13 | -450.00 | 40.39 |
Growth Rate
Revenue Growth
17.87 %
Net Income Growth
-107.69 %
Cash Flow Change
248.44 %
ROE
-104.40 %
ROCE
-353.70 %
EBITDA Margin (Avg.)
29.32 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 20 | 31 | 49 | 61 | 54 | 66 | 78 | 66 | 68 | 78 |
| Fixed Assets | 9 | 16 | 28 | 33 | 31 | 27 | 19 | 25 | 27 | 35 |
| Current Assets | 11 | 14 | 21 | 25 | 18 | 34 | 54 | 29 | 25 | 29 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12 | 15 | 21 | 29 | 23 | 39 | 59 | 39 | 38 | 39 |
| Total Liabilities | 20 | 31 | 49 | 61 | 54 | 66 | 78 | 66 | 68 | 78 |
| Current Liabilities | 8 | 9 | 17 | 21 | 23 | 23 | 22 | 11 | 9 | 12 |
| Non Current Liabilities | 8 | 5 | 10 | 8 | 8 | 8 | 5 | 6 | 10 | 16 |
| Total Equity | 4 | 17 | 22 | 32 | 23 | 35 | 51 | 48 | 49 | 50 |
| Reserve & Surplus | -2 | 3 | 7 | 17 | 8 | 20 | 35 | 33 | 33 | 34 |
| Share Capital | 6 | 9 | 12 | 15 | 15 | 15 | 15 | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 1 | 2 | -2 | 4 | 24 | -23 | -6 | -0 |
| Investing Activities | -4 | -9 | -14 | -8 | -2 | -1 | -1 | -7 | -12 | -16 |
| Operating Activities | 4 | -6 | 6 | 4 | 0 | 5 | 20 | -6 | 3 | 10 |
| Financing Activities | 0 | 15 | 10 | 6 | 0 | -0 | 6 | -10 | 2 | 5 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 38.11 % | 38.11 % | 38.11 % | 38.11 % | 36.15 % | 36.47 % | 36.47 % | 36.85 % | 38.44 % | 38.48 % | 38.48 % | 38.48 % | 38.70 % | 38.70 % | 38.70 % | 37.84 % | 38.05 % | 38.05 % | 38.05 % | 38.05 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 48.08 % | 45.99 % | 46.82 % | 46.70 % | 48.56 % | 48.38 % | 44.89 % | 44.65 % | 42.87 % | 42.89 % | 45.98 % | 45.51 % | 45.50 % | 45.34 % | 45.75 % | 45.91 % | 42.99 % | 42.75 % | 42.76 % | 46.56 % |
| Others | 13.81 % | 15.90 % | 15.06 % | 15.18 % | 15.29 % | 15.15 % | 18.64 % | 18.50 % | 18.69 % | 18.63 % | 15.53 % | 16.00 % | 15.80 % | 15.96 % | 15.55 % | 16.25 % | 18.96 % | 19.21 % | 19.19 % | 15.39 % |
| No of Share Holders | 2,740 | 3,999 | 5,499 | 5,813 | 6,144 | 6,439 | 6,449 | 6,295 | 6,061 | 5,911 | 5,933 | 5,727 | 5,749 | 5,655 | 5,607 | 5,565 | 5,497 | 5,460 | 5,444 | 5,159 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.5 | 1.2 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.38 | 2.38 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Sept 2021 |  Dividend | ₹ 0.50 /share | 07 Sept 2021 | 98.10 | 96.40 |
| 23 Sept 2022 | Dividend | ₹ 1.20 /share | 21 Sept 2022 | 83.05 | 66.35 |
| 09 Aug 2024 |  Annual General Meeting | NA | 09 Aug 2024 | 50.73 | 56.59 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 52.94 | 52.88 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 45.04 | 45.23 |
| 27 Mar 2025 |  Extraordinary General Meeting | NA | 27 Mar 2025 | 43.01 | 41.38 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 41.03 | 40.32 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 39.36 | 42.31 |
| 27 Sept 2025 | Annual General Meeting | NA | 27 Sept 2025 | 38.41 | 35.00 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 62.83 | 60.05 |
| 12 Nov 2025 | Extraordinary General Meeting | NA | 12 Nov 2025 | 55.77 | 60.05 |
Announcements
Closure Of The United States Food And Drug Administration (US FDA) Remote Regulatory Assessment Of JSTL And Issuance Of The Remote Regulatory Assessment Report - Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 20154 days ago
4 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 07, 2026
Jan 07, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 07, 2026
Jan 07, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On 02.01.2026Jan 02, 2026
Jan 02, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Update on board meetingDec 29, 2025
Dec 29, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30-12-2025.Dec 24, 2025
Dec 24, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 18, 2025
Dec 18, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationNov 12, 2025
Nov 12, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 12, 2025
Nov 12, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMNov 12, 2025
Nov 12, 2025Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 12.11.2025Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12.11.2025Nov 07, 2025
Nov 07, 2025Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 About The Completion Of US FDA Remote Interactive Evaluation (RIE) Of JSTL.Nov 07, 2025
Nov 07, 2025Extra-Ordinary General Meeting Of The Company To Be Held On Wednesday 12Th Day Of November 2025 At 10.00 A.M. Through
Video Conference / Other Audio-Visual Means (VC/OAVM)Oct 18, 2025
Oct 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 15, 2025
Oct 15, 2025Announcement under Regulation 30 (LODR)-Preferential IssueOct 15, 2025
Oct 15, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 15.10.2025Oct 15, 2025
Oct 15, 2025Board Meeting Intimation for Prior Intimation Of Board Meeting For Consideration Of Fund-Raising ProposalOct 10, 2025
Oct 10, 2025Announcement under Regulation 30 (LODR)-RetirementOct 06, 2025
Oct 06, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Outcome Of 27Th Annual General Meeting Held On 27Th September2025.Sep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Intimation Of Book Closure And Cut-Off Date For The 27Th Annual General Meeting Of Jeevan Scientific Technology Limited.Sep 05, 2025
Sep 05, 2025Annual General Meeting Of The Company Is Scheduled To Be Held On Saturday 27Th Day Of September 2025 At 10.00 A.M Through Video Conference VC / Other Audio-Visual Means.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Annual General Meeting Of The Company Is Scheduled To Be Held On Saturday 27Th Day Of September 2025 At 10.00 A.M Through Video Conference "VC" I Other Audio-Visual Means.Sep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2025
Aug 14, 2025Un Audited Financial Results For The Quarter Ended 30.06.2025Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.08.2025Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for The Meeting To Be Held On 14.08.2025Aug 06, 2025
Aug 06, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 07.08.2025Aug 01, 2025
Aug 01, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 19, 2025
Jul 19, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
May 31, 2025Technical Indicators
RSI(14)
Neutral 38.44
ATR(14)
Volatile 2.45
STOCH(9,6)
Oversold 2.77
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -1.08
ADX(14)
Weak Trend 24.70
UO(9)
Bullish 28.59
ROC(12)
Downtrend And Accelerating -15.21
WillR(14)
Oversold -100.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
